6 completed. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
Follow Cabergoline: new trials by email Literature Review of Cabergoline trials Research Report on Cabergoline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion Cabergoline, Placebo - Lactation Suppressed, Second Trimester Abortion | Phase 4 | Completed | Northwestern University | 15 | 2023-12-18 | 2026-10-15 |
| Cabergoline Before or After Oocyte Collection for Follicular Resolution Cabergoline Pill - Infertility, Female | Phase 4 | Completed | Fertility Center of Las Vegas | 70 | 2019-09-23 | 2021-06-14 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients Sandostatin LAR, pegvisomant, cabergoline - Acromegaly | Phase 4 | Completed | Novartis Pharmaceuticals | 70 | 2006-09-01 | 2017-03-03 |
| Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly Octreotide acetate and cabergoline/Octrotide and Somavert - Acromegaly | Phase 4 | Completed | Novartis Pharmaceuticals | 20 | 2006-03-01 | 2017-03-06 |
| Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease Cabergoline, Levodopa - Parkinson's Disease | Phase 4 | Completed | Technische Universität Dresden | 39 | 2005-02-01 | 2012-12-18 |
Acromegaly (3) · Pituitary Neoplasms (2) · Brain Neoplasms (1) · Dumping Syndrome (1) · Infertility, Female (1) · Melanoma (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Parkinson Disease (1) · Pituitary ACTH Hypersecretion (1) · Prostatic Neoplasms (1)
Novartis Pharmaceuticals (2) · Fertility Center of Las Vegas (1) · Northwestern University (1) · RECORDATI GROUP (1) · Technische Universität Dresden (1)
Germany (3) · United States (3) · France (2) · Italy (2) · Poland (2) · Portugal (2) · Switzerland (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Greece (1) · Hungary (1) · India (1)
Bruce Shapiro, MD (1) · Heinz Reichmann, MD (1)
2005 (1)